DK0914043T3 - Implanterbare agarose-kollagen-korn, som indeholder celler, der dannet et diffunderbart produkt, og anvendelser heraf - Google Patents

Implanterbare agarose-kollagen-korn, som indeholder celler, der dannet et diffunderbart produkt, og anvendelser heraf

Info

Publication number
DK0914043T3
DK0914043T3 DK97915180T DK97915180T DK0914043T3 DK 0914043 T3 DK0914043 T3 DK 0914043T3 DK 97915180 T DK97915180 T DK 97915180T DK 97915180 T DK97915180 T DK 97915180T DK 0914043 T3 DK0914043 T3 DK 0914043T3
Authority
DK
Denmark
Prior art keywords
containing cells
grains containing
agarose
diffusible product
implantable
Prior art date
Application number
DK97915180T
Other languages
English (en)
Inventor
Kanti Jain
Albert L Rubin
Shirin Asina
Barry Smith
Kurt Stenzel
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/745,063 external-priority patent/US5888497A/en
Application filed by Rogosin Inst filed Critical Rogosin Inst
Application granted granted Critical
Publication of DK0914043T3 publication Critical patent/DK0914043T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Dispersion Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK97915180T 1996-04-03 1997-03-21 Implanterbare agarose-kollagen-korn, som indeholder celler, der dannet et diffunderbart produkt, og anvendelser heraf DK0914043T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62559596A 1996-04-03 1996-04-03
US08/745,063 US5888497A (en) 1996-04-03 1996-11-07 Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
PCT/US1997/004548 WO1997036495A1 (en) 1996-04-03 1997-03-21 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof

Publications (1)

Publication Number Publication Date
DK0914043T3 true DK0914043T3 (da) 2004-02-09

Family

ID=27089961

Family Applications (2)

Application Number Title Priority Date Filing Date
DK97915180T DK0914043T3 (da) 1996-04-03 1997-03-21 Implanterbare agarose-kollagen-korn, som indeholder celler, der dannet et diffunderbart produkt, og anvendelser heraf
DK03018701T DK1382346T3 (da) 1996-04-03 1997-03-21 Konditioneret medium og diffunderbare biologiske produkter fremstillet ved inkubering af indesluttede celler

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK03018701T DK1382346T3 (da) 1996-04-03 1997-03-21 Konditioneret medium og diffunderbare biologiske produkter fremstillet ved inkubering af indesluttede celler

Country Status (15)

Country Link
EP (2) EP1382346B1 (da)
JP (2) JP3765039B2 (da)
CN (2) CN1119080C (da)
AT (2) ATE250858T1 (da)
AU (1) AU722109C (da)
CA (1) CA2250880C (da)
DE (2) DE69725317T2 (da)
DK (2) DK0914043T3 (da)
ES (2) ES2290390T3 (da)
FI (1) FI120332B (da)
IL (1) IL126442A0 (da)
NO (1) NO320334B1 (da)
NZ (2) NZ331960A (da)
PT (1) PT914043E (da)
WO (1) WO1997036495A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297331B2 (en) 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
US6224912B1 (en) 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US6303151B1 (en) * 1996-04-03 2001-10-16 The Rogosin Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
NO983911D0 (no) 1998-08-26 1998-08-26 Norsk Hydro As Alginatkapsler til bruk ved behandling av hjernesvulst
AU2003264652B2 (en) * 1998-11-09 2006-09-14 The Rogosin Institute Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
US8257715B1 (en) 2004-08-26 2012-09-04 University Of Notre Dame Tissue vaccines and uses thereof
US8778362B2 (en) 2005-10-27 2014-07-15 University Of Notre Dame Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
US8778360B2 (en) * 2005-10-27 2014-07-15 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US9308252B2 (en) 2005-10-27 2016-04-12 Cook Biotech, Inc. Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
US8802113B2 (en) 2005-10-27 2014-08-12 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US9283266B2 (en) 2008-02-28 2016-03-15 University Of Notre Dame Metastasis inhibition preparations and methods
US8846059B2 (en) 2009-12-08 2014-09-30 University Of Notre Dame Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
AP2014007623A0 (en) * 2012-01-31 2014-05-31 Rogosin Inst Improved method for manufacture of macrobeads
JP7763450B2 (ja) * 2018-02-02 2025-11-04 ウェイク・フォレスト・ユニバーシティ・ヘルス・サイエンシーズ 免疫療法に関するオルガノイドならびにそれを調製および使用する方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE441009B (sv) * 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
US4798786A (en) * 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
CA1196862A (en) * 1983-06-01 1985-11-19 Connaught Laboratories Limited Microencapsulation of living tissue and cells
US4663286A (en) * 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
SE8604684L (sv) * 1986-11-03 1988-05-04 Excorim Kommanditbolag Sett att belegga fasta partiklar med en hydrofil gel samt genom settet belagda partiklar
JP2691557B2 (ja) * 1988-04-15 1997-12-17 興研株式会社 人の悪性腫瘍細胞増殖抑制剤
US5053332A (en) * 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
US5241051A (en) * 1992-04-24 1993-08-31 Research Development Foundation Oncoinhibin
RU2208636C2 (ru) * 1994-01-13 2003-07-20 Дзе Рогозин Институт Макрогранула с секреторными клетками, способ ее получения и способ лечения заболеваний, вызванных нарушением функционирования секреторных клеток
US5651980A (en) * 1994-04-15 1997-07-29 Biohybrid Technologies, Inc. Methods of use of uncoated gel particles

Also Published As

Publication number Publication date
WO1997036495A1 (en) 1997-10-09
CA2250880C (en) 2008-01-15
PT914043E (pt) 2004-02-27
DE69725317T2 (de) 2004-07-29
ES2290390T3 (es) 2008-02-16
JP2001503380A (ja) 2001-03-13
HK1019037A1 (en) 2000-01-21
AU722109C (en) 2001-07-19
FI981957L (fi) 1998-12-02
HK1066026A1 (en) 2005-03-11
CN1119080C (zh) 2003-08-27
EP0914043A1 (en) 1999-05-12
FI120332B (fi) 2009-09-30
JP2005104987A (ja) 2005-04-21
CN1215309A (zh) 1999-04-28
JP3765039B2 (ja) 2006-04-12
ATE374034T1 (de) 2007-10-15
AU2218897A (en) 1997-10-22
NO984627D0 (no) 1998-10-02
CN1296477C (zh) 2007-01-24
CN1495253A (zh) 2004-05-12
CA2250880A1 (en) 1997-10-09
DE69725317D1 (de) 2003-11-06
EP0914043B1 (en) 2003-10-01
ATE250858T1 (de) 2003-10-15
NZ337109A (en) 2004-12-24
AU722109B2 (en) 2000-07-20
JP4480152B2 (ja) 2010-06-16
NO320334B1 (no) 2005-11-21
DE69738170D1 (de) 2007-11-08
EP0914043A4 (en) 2001-08-29
NZ331960A (en) 1999-10-28
DE69738170T2 (de) 2008-01-24
EP1382346B1 (en) 2007-09-26
FI981957A0 (fi) 1998-09-11
NO984627L (no) 1998-11-30
EP1382346A1 (en) 2004-01-21
ES2206696T3 (es) 2004-05-16
DK1382346T3 (da) 2008-01-28
IL126442A0 (en) 1999-08-17

Similar Documents

Publication Publication Date Title
DE69628791D1 (de) Absorbierende Zusammensetzung, absorbierendes Material, und ein, das absorbierende Material enthaltende, absorbierendes Produkt.
NO982722L (no) Absorbenter for fosfat fra et vanndig medium, samt fremstilling og anvendelse av absorbenten
NO984627D0 (no) Implanterbare, agarose-kollagenperler inneholdende celler som produserer et diffuserbart biologisk produkt og anvendelser derav
DE69633135D1 (de) Fluorierte oniumsatze, härtbare zusammensetzungen, welche selbige enthalten, und härtungsverfahren unter deren verwendung
BR8107071A (pt) Valvula cardiaca para protese
FI854747A7 (fi) Reniiniä inhibioivat dipeptidit, prosessi niiden valmistamiseksi ja niiden käyttö.
DE69102903D1 (de) Überzogenes Vitamin-C-Präparat für Tierfutter, dessen Herstellung und Verwendung.
WO2000004865A3 (en) Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
DE3876400D1 (de) Aminosaeure-imid-derivate, ihre verwendung und diese enthaltende medizinische zusammensetzungen.
ATE268385T1 (de) Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose
CA2185112A1 (en) Humanized monoclonal antibodies against human interleukin-4
FI970103A7 (fi) Mikro-organismeja sisältävä raekoostumus, menetelmä sen valmistamiseks i ja sen käyttö
AU1828388A (en) Promoters for the expression of foreign dna in methylotrophic bacteria, the obtaining thereof and the use thereof
MX159435A (es) Valvula de retencion para fines medicos,especialmente para cateteres de globo
DE68919259D1 (de) N-Phenylimide, ihre Herstellung und Verwendung.
DE3685743D1 (de) Anthracyclinderivate, ihre verwendung als antitumorsubstanzen und ihre herstellung.
DE69508072D1 (de) Pulverzusammensetzung zur detektion oberflächenfehler, ihre verwendung und applikator
EP0112299A3 (en) Method for superoxidic-dismutasis purification via chromatography by affinity
BG46743A3 (en) Method for preparing of alkanoyl anilides
AU3845395A (en) Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
AU3406089A (en) Novel strobilurine derivatives, their preparation and their use
DK0804098T3 (da) Filter til tobaksrøg
ATE41674T1 (de) L-glutaminsaeure-oxidase, ihre gewinnung und ihre verwendung.
IT8020138A0 (it) Nuovi derivati 3 azetidiniletti-1-fenil-2-imidazolidinonici ad attivita' neurolettica, procedimento per la loro preparazione e loro impiego.
FI905060A7 (fi) Menetelmä sellaisten liposomien ja/tai biologisten solujen valmistamis eksi, joihin on absorboitunut aineita, sekä niiden käyttö